Afeditab cr side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Afeditab cr. Common side effects include dizziness, abdominal pain among females, and acquired oesophageal web, anaemia among males.
The phase IV clinical study is created by eHealthMe based on 51 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
51 people who take Afeditab Cr and have side effects are studied.
What is Afeditab Cr?
Afeditab cr has active ingredients of nifedipine. Currently, eHealthMe is studying from 54 Afeditab cr users.
Number of Afeditab cr reports submitted per year:

Afeditab Cr side effects by time on the drug*:
< 1 month:
- Drug exposure during pregnancy
1 - 6 months:
- Drug ineffective
- Peripheral swelling
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
- Anxiety disorder
- Cardiac failure congestive
- Cellulitis (infection under the skin)
- Abdominal discomfort
- Acariasis (disease caused by mites)
- Chills (felling of cold)
- Circulatory collapse
- Disturbance in attention
- Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
- Dysphonia (speech disorder attributable to a disorder of phonation)
Afeditab Cr side effects by gender *:
female:
- Dizziness
- Abdominal pain
- Anxiety disorder
- Cellulitis (infection under the skin)
- Death
- Abdominal discomfort
- Acariasis (disease caused by mites)
- Acute generalised exanthematous pustulosis (acute febrile drug eruption)
- Anxiety
- Chills (felling of cold)
male:
- Acquired oesophageal web (structural abnormalities in the oesophagus)
- Anaemia (lack of blood)
- Cardiac failure congestive
- Acute generalised exanthematous pustulosis (acute febrile drug eruption)
- Anxiety
- Drug ineffective
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Local swelling (swelling at the site of some application of substance or injury)
- Nasopharyngitis (inflammation of the nasopharynx)
- Peripheral swelling
Afeditab Cr side effects by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Acute generalised exanthematous pustulosis (acute febrile drug eruption)
- Circulatory collapse
30-39:
n/a
40-49:
- Anxiety disorder
- Anxiety
50-59:
- Dizziness
- Anaemia (lack of blood)
- Cardiac failure congestive
- Anxiety
- Hypotension (abnormally low blood pressure)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Pneumonia
60+:
- Chills (felling of cold)
- Drug ineffective
- Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematocrit decreased
- Local swelling (swelling at the site of some application of substance or injury)
- Nasopharyngitis (inflammation of the nasopharynx)
- Peripheral swelling
- Abdominal pain
* Approximation only. Some reports may have incomplete information.
Do you take Afeditab cr?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on nifedipine (the active ingredients of Afeditab cr) and Afeditab cr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Afeditab cr:
- Afeditab cr (54 reports)
All Afeditab cr side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clonidine and Azstarys drug interaction - 11 seconds ago
- Valtrex and Sjogren Syndrome - 11 seconds ago
- Benztropine Mesylate and Glycopyrrolate drug interaction - 13 seconds ago
- Oxycodone and Actos drug interaction - 15 seconds ago
- Protriptyline Hydrochloride and Warfarin Sodium drug interaction - 20 seconds ago
- Sandostatin Lar and Application Site Erythema - 28 seconds ago
- Zonegran and Ditropan drug interaction - 33 seconds ago
- Topamax and Rotator Cuff Repair - 43 seconds ago
- Methylprednisolone and Ureteric Cancer - 45 seconds ago
- Naprosyn and Magnesium Sulfate drug interaction - 47 seconds ago